TERT-IN-1

CAS No. 257891-65-9

TERT-IN-1( —— )

Catalog No. M37513 CAS No. 257891-65-9

TERT-IN-1 has anti-HIV activity and can be used to study HIV infection.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 248 Get Quote
5MG 376 Get Quote
10MG 550 Get Quote
25MG 820 Get Quote
50MG 1122 Get Quote
100MG 1485 Get Quote
200MG 2007 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TERT-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    TERT-IN-1 has anti-HIV activity and can be used to study HIV infection.
  • Description
    TERT-IN-1 has anti-HIV activity and can be used to study HIV infection.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV Protease
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    257891-65-9
  • Formula Weight
    321.87
  • Molecular Formula
    C16H20ClN3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S=C1NC2=CC=C(Cl)C3=C2N1CC(N(CC=C(C)C)C3)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Decanoyl-RVKR-CMK

    Subtilisin/Kex2p-like proprotein convertase inhibitor; blocks activity of all seven convertases (PC1, PC2, PC4, PACE4, PC5, PC7 and furin). Abolishes proET-1 processing in endothelial cells; inhibits regulated secretion of the neuronal polypeptide VGF in PC12 cells.

  • Terameprocol

    Terameprocol is a synthetic tetra-methylated derivative of nordihydroguaiaretic acid (NDGA) and transcriptional inhibitor with potential antiviral, antiangiogenic, and antineoplastic activities. Terameprocol showed the strongest anti-HIV activity.

  • GS-6207

    GS-6207 (GS6207, GS-CA1) is a potent, selective inhibitor of HIV-1 capsid function with potency and potential to be clinically effective against a broad range of HIV-1 strains.